newsfilter
← Latest News
GlobeNewswire·

INVO Fertility Receives Nasdaq Notification Regarding Late Filing of Annual Report on Form 10-K

  • INVO Fertility, Inc. received a notice from Nasdaq on April 23, 2026, for non-compliance with Listing Rule 5250(c)(1) due to failing to file its 2025 Annual Report on Form 10-K by the April 15, 2026 deadline.
  • The delay in filing is attributed to the need for additional time to review complex accounting matters including tax provisions, warrant accounting, & variable interest entity accounting.
  • The notice has no immediate effect on the listing of INVO's common stock, which continues to trade on Nasdaq under the symbol "IVF".
  • The Company has 60 calendar days from the notice date to submit a compliance plan to Nasdaq & may receive up to 180 calendar days from the original due date to regain compliance if the plan is accepted.
  • INVO Fertility operates four US-based fertility clinics, distributes its proprietary INVOcell device, & focuses on expanding access to assisted reproductive technology.